Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER_GOV × Lymphoma × Clear all

Phase

Phase NA 10 Phase 2 5 Phase 4 2 Phase 1/2 2 Phase 1 2 Phase EARLY_PHASE1 1 Phase 3 1

Status

Sponsor Class

OTHER 79 INDUSTRY 40 NETWORK 32 NIH 30 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Breast Neoplasms 14 Stomach Neoplasms 11 Uterine Cervical Neoplasms 10 Carcinoma, Non-Small-Cell Lung 10 Neoplasms 8 Ovarian Neoplasms 7 Esophageal Neoplasms 7 Fallopian Tube Neoplasms 6 Carcinoma, Ovarian Epithelial 6 Recurrence 4 Neoplasm Metastasis 4 Head and Neck Neoplasms 4 Colorectal Neoplasms 4 Colonic Neoplasms 4 Carcinoma, Hepatocellular 4 Rectal Neoplasms 3 Nasopharyngeal Carcinoma 3 Multiple Myeloma 3 Mouth Neoplasms 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Glioblastoma 3 Esophageal Squamous Cell Carcinoma 3 Urinary Bladder Neoplasms 2 Prostatic Neoplasms 2 Polycystic Ovary Syndrome 2 Peripheral Nervous System Diseases 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Lung Neoplasms 2

Interventions

Platelet Transfusion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01642563 2015-07-28

IPTAS

Centro Nazionale Sangue

Phase 3 Terminated

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡